Посещений:
The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs Nature, 434: 234-238, March 10, 2005. | |
|
Representing the 60 trillion cells that build a human body, a sperm and an egg meet, recognize each other, and fuse to form a new generation of life. The factors involved in this important membrane fusion event, fertilization, have been sought for a long time1. Recently, CD9 on the egg membrane was found to be essential for fusion, but sperm-related fusion factors remain unknown. Here, by using a fusion-inhibiting monoclonal antibody and gene cloning, we identify a mouse sperm fusion-related antigen and show that the antigen is a novel immunoglobulin superfamily protein. We have termed the gene Izumo and produced a gene-disrupted mouse line. Izumo-/- mice were healthy but males were sterile. They produced normal-looking sperm that bound to and penetrated the zona pellucida but were incapable of fusing with eggs. Human sperm also contain Izumo and addition of the antibody against human Izumo left the sperm unable to fuse with zona-free hamster eggs.
Рис.1. | Identification and characterization of Izumo. |
Исследователи идентифицировали белок спермиев, которые существенен для слияния мембран спермия и яйцеклетки во время оплодотворения (Nature). Они назвали белок "Izumo," по-японски брачный.
Okabe обнаружили этот белок еще в 1987, когда его группа В 2000 они опубликовали В своей последней работе исследователи установили роль Izumo в оплодотвоврении путем получения нокаутных линий мышей. Получены однозначные резулдьтаты. Мыши были здоровы, но самцы были стерильны. Их спермии соединялись с и проникали в zona pellucida, но не могли сливаться с яйцеклеткой.
"This paper will provide a jolt of energy to the field," заявил Okabe предполагает существование сопутствующих белков, участвующих в слиянии. "We think that Izumo is not the only factor affecting fusion. We just opened the door for studying the fusion mechanism," he said. "Now we have to find other factors which are also involved in fusion, using Izumo and CD9."
|